Literature DB >> 33055191

Prolonged SARS-CoV-2 Viral RNA Shedding and IgG Antibody Response to SARS-CoV-2 in Patients on Hemodialysis.

Aisha Shaikh1,2, Etti Zeldis3,2, Kirk N Campbell2, Lili Chan2.   

Abstract

Entities:  

Keywords:  COVID-19; RNA; hemodialysis; immunoglobulin G; viral

Mesh:

Substances:

Year:  2020        PMID: 33055191      PMCID: PMC7863659          DOI: 10.2215/CJN.11120720

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  3 in total

Review 1.  Immunization in end-stage renal disease: opportunity to improve outcomes.

Authors:  Ritu Soni; Bruce Horowitz; Mark Unruh
Journal:  Semin Dial       Date:  2013-06-10       Impact factor: 3.455

2.  Virological assessment of hospitalized patients with COVID-2019.

Authors:  Roman Wölfel; Victor M Corman; Wolfgang Guggemos; Michael Seilmaier; Sabine Zange; Marcel A Müller; Daniela Niemeyer; Terry C Jones; Patrick Vollmar; Camilla Rothe; Michael Hoelscher; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Rosina Ehmann; Katrin Zwirglmaier; Christian Drosten; Clemens Wendtner
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

3.  IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis.

Authors:  An S De Vriese; Marijke Reynders
Journal:  Am J Kidney Dis       Date:  2020-06-05       Impact factor: 8.860

  3 in total
  10 in total

1.  Machine Learning for Prediction of Patients on Hemodialysis with an Undetected SARS-CoV-2 Infection.

Authors:  Caitlin K Monaghan; John W Larkin; Sheetal Chaudhuri; Hao Han; Yue Jiao; Kristine M Bermudez; Eric D Weinhandl; Ines A Dahne-Steuber; Kathleen Belmonte; Luca Neri; Peter Kotanko; Jeroen P Kooman; Jeffrey L Hymes; Robert J Kossmann; Len A Usvyat; Franklin W Maddux
Journal:  Kidney360       Date:  2021-01-13

2.  Clinical Course of SARS-CoV-2 Infection in Adults with ESKD Receiving Outpatient Hemodialysis.

Authors:  Ana Cecilia Bardossy; Lauren Korhonen; Sabrina Schatzman; Paige Gable; Carolyn Herzig; Nicole E Brown; Elizabeth Beshearse; Kate Varela; Sarah Sabour; Amanda K Lyons; Rahsaan Overton; Matthew Hudson; Alfonso C Hernandez-Romieu; Jorge Alvarez; Kaylin Roman; Mark Weng; Elizabeth Soda; Priti R Patel; Crystal Grate; Lorien S Dalrymple; Rebecca L Wingard; Natalie J Thornburg; Alison S Laufer Halpin; Jennifer M Folster; Melissa Tobin-D'Angelo; Janice Lea; Ibironke Apata; L Clifford McDonald; Allison C Brown; Preeta K Kutty; Shannon Novosad
Journal:  Kidney360       Date:  2021-09-22

3.  Presence of specific SARS-COV2 antibodies in hemodialysis patients and their caregivers after the first wave of COVID-19.

Authors:  Thomas Robert; Guillaume Lano; Noémie Resseguier; Mickaël Bobot; Dammar Bouchouareb; Stéphane Burtey; Xavier de Lamballerie; Jean Dhorne; Bertrand Dussol; Ariane Duval; Julien Faraut; Toscane Fourié; Philippe Giaime; Mourad Hallah; Dominique Jaubert; Océane Jéhel; Tristan Legris; Stéphane Liotatis; Valérie Moal; Laetitia Ninove; Nathalie Pedinielli; Marion Pelletier; Manon Romeu-Giannoli; Mariela Saba; Marion Sallée; Laurent Samson; Adriana Saveanu; Violaine Scarfoglière; Pascale Sebahoun; Romain Vial; Clarissa Von Kotze; Philippe Brunet; Gaëtan Lebrun; Stanislas Bataille; Noémie Jourde-Chiche
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

Review 4.  The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review.

Authors:  Gaetano Alfano; Annachiara Ferrari; Riccardo Magistroni; Francesco Fontana; Gianni Cappelli; Carlo Basile
Journal:  J Nephrol       Date:  2021-08-21       Impact factor: 3.902

5.  Trajectories of clinical and laboratory characteristics associated with COVID-19 in hemodialysis patients by survival.

Authors:  Sheetal Chaudhuri; Rachel Lasky; Yue Jiao; John Larkin; Caitlin Monaghan; Anke Winter; Luca Neri; Peter Kotanko; Jeffrey Hymes; Sangho Lee; Yuedong Wang; Jeroen P Kooman; Franklin Maddux; Len Usvyat
Journal:  Hemodial Int       Date:  2021-08-10       Impact factor: 1.543

6.  COVID-19 re-infection in Shahroud, Iran: a follow-up study.

Authors:  Fariba Zare; Maryam Teimouri; Ahmad Khosravi; Marzieh Rohani-Rasaf; Reza Chaman; Ali Hosseinzadeh; Hozhabr Jamali Atergeleh; Ehsan Binesh; Mohammad Hassan Emamian
Journal:  Epidemiol Infect       Date:  2021-04-19       Impact factor: 2.451

7.  Antibody Response to mRNA-1273 SARS-CoV-2 Vaccine in Hemodialysis Patients with and without Prior COVID-19.

Authors:  Lili Chan; Nicholas Fuca; Etti Zeldis; Kirk N Campbell; Aisha Shaikh
Journal:  Clin J Am Soc Nephrol       Date:  2021-05-24       Impact factor: 10.614

8.  IgG SARS-CoV-2 antibodies persist at least for 10 months in patients on hemodialysis.

Authors:  C Dudreuilh; T Roper; C Breen; P Chowdhury; S Douthwaite; N Kumar; D A Moutzouris
Journal:  Kidney Int Rep       Date:  2021-04-08

9.  Effectiveness of COVID-19 Vaccines in Patients Under Maintenance Hemodialysis.

Authors:  Waleed H Mahallawi; Nadir A Ibrahim; Walaa A Mumena
Journal:  Risk Manag Healthc Policy       Date:  2021-12-30

Review 10.  COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment.

Authors:  Khalil El Karoui; An S De Vriese
Journal:  Kidney Int       Date:  2022-02-14       Impact factor: 18.998

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.